Science Exchange, a top provider of SaaS solutions for life sciences procurement and supplier management, has announced its acquisition by Waud Capital Partners, a private equity firm focused on growth in the software and healthcare sectors. This acquisition represents a major milestone for Science Exchange, enhancing its performance, growth potential, and software capabilities. The partnership with Waud Capital will empower Science Exchange to accelerate its mission to innovate the purchasing and supplier orchestration landscape for life sciences organizations.
Waud Capital Partners has acquired Science Exchange, a leader in life sciences procurement technology, following a detailed analysis of the market. Science Exchange is recognized for its modern cloud-based supplier orchestration platform, which operates on a transparent SaaS subscription model. This platform digitizes procurement workflows, including supplier discovery, compliance management, RFPs, purchase orders, and invoicing. It has quickly gained popularity among leading global pharmaceutical and biotech companies, offering significant cost savings and enhancing collaboration.
“With Waud Capital’s support, we’re ready to strengthen our position as the premier SaaS supplier orchestration platform in the life sciences sector,” said Elizabeth Iorns, Ph.D., CEO & Co-Founder of Science Exchange. “This partnership will accelerate our product innovation and growth, enabling us to provide even greater value to our customers and expedite the market entry of therapeutics.”
Matthew Clary, Partner at Waud Capital, remarked on the acquisition as a testament to Science Exchange’s robust technology and leadership vision. Paul Sutphin, Principal at Waud Capital, noted the unique customer satisfaction with Science Exchange’s procurement software, highlighting the substantial time and cost savings it offers.
Under Waud Capital’s ownership, Science Exchange plans to enhance its product offerings and market presence while retaining its current leadership team, including Iorns, Dan Knox, and Tzlil Hadass. Mark Layden from Waud Capital will join as Executive Chairman, expressing excitement about Science Exchange’s potential for continued innovation and growth.
About Science Exchange
Science Exchange is the first cloud software platform for procurement and supplier orchestration in the life sciences. It streamlines procurement processes from vendor discovery to payment, supporting top pharmaceutical and biotech organizations in accelerating research and advancing their programs efficiently.
